Antithrombin vs placebo
Neonatal mortality · very preterm infants at risk of intraventricular hemorrhage
It is very uncertain whether antithrombin changes neonatal mortality (all‐cause, < 28 days of age) compared with placebo (very low certainty).
1 finding from 1 review
- Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants 2016 · Cochrane Headline outcomes onlyRR 2 [0.62, 6.45]2 studies · 182 participantsVery low